Efficacy of Novel Non-Chemotherapy Combinations Against AML Cells with Mutant NPM1

被引:0
|
作者
Mill, Christopher Peter [1 ]
Fiskus, Warren C. [2 ]
Davis, John A. [3 ]
Das, Kaberi [4 ]
Birdwell, Christine E. [3 ]
Kadia, Tapan M. [5 ]
Sasaki, Koji [2 ]
Takahashi, Koichi [2 ]
DiNardo, Courtney D. [2 ]
Loghavi, Sanam [6 ]
Daver, Naval [2 ]
Bhalla, Kapil N. [2 ]
机构
[1] MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] UT MD Anderson Canc Ctr, Houston, TX USA
[5] MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
关键词
D O I
10.1182/blood-2022-169584
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:5860 / 5861
页数:2
相关论文
共 50 条
  • [31] Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1
    Warren Fiskus
    Christopher P. Mill
    Christine Birdwell
    John A. Davis
    Kaberi Das
    Steffen Boettcher
    Tapan M. Kadia
    Courtney D. DiNardo
    Koichi Takahashi
    Sanam Loghavi
    Michael J. Soth
    Tim Heffernan
    Gerard M. McGeehan
    Xinjia Ruan
    Xiaoping Su
    Christopher R. Vakoc
    Naval Daver
    Kapil N. Bhalla
    Blood Cancer Journal, 13
  • [32] Two novel NPM1 mutations in a therapy-responder AML patient
    Pianta, Annalisa
    Fabbro, Dora
    Damiani, Daniela
    Tiribelli, Mario
    Fanin, Renato
    Franzoni, Alessandra
    Romanello, Milena
    Tell, Gianluca
    Di Loreto, Carla
    Damante, Giuseppe
    HEMATOLOGICAL ONCOLOGY, 2010, 28 (03) : 151 - 155
  • [33] Superior Efficacy of Co-treatment with NPM1 Antagonist and FLT3 Inhibitor or Pan-histone Deacetylase Inhibitor Against Cultured and Primary Human AML Cells Co-expressing Mutant NPM1 and FLT3-ITD
    Balusu, R.
    Huffman, N.
    Fiskus, W.
    Smith, J.
    Peth, K.
    Hembruff, S.
    Rao, R.
    Ganguly, S.
    McGuirk, J.
    Bhalla, K. N.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 159 - 159
  • [34] A Curious Novel Combination of Nucleophosmin (NPM1) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of NPM1 in Acute Myeloid Leukemia (AML)
    Venanzi, Alessandra
    Rossi, Roberta
    Martino, Giovanni
    Annibali, Ombretta
    Avvisati, Giuseppe
    Mameli, Maria Grazia
    Sportoletti, Paolo
    Tiacci, Enrico
    Falini, Brunangelo
    Martelli, Maria Paola
    GENES, 2021, 12 (09)
  • [35] CHARACTERISATION OF A NEW MONOCLONAL ANTIBODY RAISED AGAINST THE MUTANT A OF THE NPM1 PROTEIN: ITS APPLICATION IN THE DIAGNOSIS OF THE NPMC plus AML
    Gruszka, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 334 - 334
  • [36] THE ABSENT/LOW EXPRESSION OF CD34 IN NPM1-MUTATED AML IS NOT RELATED TO THE CYTOPLASMIC DISLOCATION OF NPM1 MUTANT
    Pianigiani, G.
    Rocchio, F.
    Peruzzi, S.
    Andresen, V.
    Martelli, M. P.
    Brunetti, L.
    Falini, B.
    HAEMATOLOGICA, 2022, 107 : 68 - 69
  • [37] Expression of a Dominant Negative Mutant of NPM1 in Neuroblastoma Cells Results in Altered Localization of NPM1.
    Mohiuddin, Saad
    Campbell, Jaclyn
    Keeler, Kelly
    Kristjansdottir, Kolla
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2018, 54 (07) : 540 - 540
  • [38] Combinatorial Genetics Uncovers Novel Targets for the Treatment of Npm1/Cohesin Mutated AML
    Meyer, Alison E.
    Stelloh, Cary
    Fisher, Joseph B.
    Pulakanti, Kirthi
    Vassiliou, George S.
    Viny, Aaron D.
    Levine, Ross L.
    Rao, Sridhar
    BLOOD, 2019, 134
  • [39] Combinatorial Genetics Uncovers Novel Tagrets for the Treatment of Npm1/Cohesin Mutated AML
    Meyer, Alison E.
    Stelloh, Cary
    Fisher, Joseph B.
    Pulakanti, Kirthi
    Vassiliou, George S.
    Viny, Aaron D.
    Levine, Ross L.
    Rao, Sridhar
    BLOOD, 2018, 132
  • [40] ARSENIC TRIOXIDE AND ALL-TRANS-RETINOIC ACID TARGET NPM1 MUTANT ONCOPROTEIN LEVELS AND INDUCE APOPTOSIS IN NPM1-MUTATED AML CELLS
    Martelli, M. P.
    Gionfriddo, I.
    Mezzasoma, F.
    Milano, F.
    Pierangeli, S.
    Pettirossi, V.
    Rossi, R.
    Strozzini, F.
    Vetro, C.
    Brunetti, L.
    Sportoletti, P.
    Tiacci, E.
    Di Raimondo, F.
    Falini, B.
    HAEMATOLOGICA, 2015, 100 : 210 - 210